For Healthcare Providers

You are accessing a US-based website. The owner of the Website is based in the State of Georgia in the United States. We provide this Website for use only by persons located in the United States. We make no claims that the Website or any of its content is accessible or appropriate outside of the United States. Access to the Website may not be legal by certain persons or in certain countries. If you access the Website from outside the United States, you do so on your own initiative and are responsible for compliance with local laws.

What are the NEW DAY Study Objectives?

The NEW DAY Study evaluates an FDA-approved long-acting steroid delivery system treatment option and an FDA-approved short-acting anti-VEGF treatment option.

For More Information Visit:
Clinicaltrials.gov or

Email Us

The NEW DAY Study can also be found by searching NCT04469595 on clinicaltrials.gov

What are the NEW DAY Study Objectives?

For More Information Visit:Clinicaltrials.gov or

Explore more

For More Information Visit:
Clinicaltrials.gov or